pHOXBIO

pHOXBIO is a private biopharmaceutical company developing prophylactic nasal spray products intended to prevent airborne respiratory viral infections. The company is associated with Raphael Labs and has focused on pHOXWELL, a self-administered nasal spray studied for prevention of SARS-CoV-2 infection in high-risk healthcare workers, as well as pHOXGEN, another respiratory-virus prevention program. Its products are described as using natural virucides together with the proprietary Vita Raphael formulation to create a variant-agnostic barrier against infection in the nasal mucosa. Publicly available information indicates the company has operated from Ireland and the UK, remains private, and has not disclosed a broad diversified pipeline beyond its respiratory prophylaxis assets.